Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Outcome Of Board Meeting Held On February 13Th 2023

In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held onFebruary 13th 2023has transacted the following business: Approved unaudited standalone results for the quarter and period ended December 31st, 2022. The Board meeting commenced by 04:45 P.M and ended by 6:30 P.M
13-02-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Outcome for Outcome Of Board Meeting Held On February13th 2023

In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held onFebruary 13th 2023has transacted the following business: Approved unaudited standalone results for the quarter and period ended December 31st, 2022. The Board meeting commenced by 04:45 P.M and ended by 6:30 P.M
13-02-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Resignation of Director

Pursuant to Regulation 30 read with para 7A of Schedule III we hereby inform that R Subramanian as Independent Non-Executive Director holding DIN- 00357153 has resigned from office consequent to the resignation letter dated 10th February 2023. The company and the Board of Directors wholeheartedly thank R Subramanian for the services rendered by him during his stint as Independent Non-Executive Director. Letter of resignation and names of listed entities in which the director holds directorship, category of director ship and membership are attached with the intimation.
10-02-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for Intimation Of Board Meeting

Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, we wish to inform you that the Board of Directors of the company will be meeting on Monday , February 13,2023 inter-alia to consider the following: - 1. Unaudited Standalone Financial Results of the company for the quarter and year ended December 31, 2022. Further, with reference to our earlier intimation December 31, 2022, we wish to inform that, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from February 16, 2023 onwards. Request you to kindly take the same on your record.
27-01-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Reconciliation Of Share Capital Audit For The Quarter Ended 31.12.2022 As Per Regulation 76 Of The SEBI (DP) Regulation,2018

We are enclosing herewith the Reconciliation of Share Capital Audit Report for the quarter ended 31st December 2022 as per Regulation 76 of the SEBI (Depositories and Participants) Regulation 2018 and in terms of Circular No. CIR/MRD/DP/30/2010 dated 06.09.2010 issued by SEBI.
14-01-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Based on the confirmation received from S.K.D.C. Consultants Limited, Registrar and Transfer Agent of the company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within 15 days of receipt of certificate of security and the details are furnished to the stock exchanges. Further, we, certify that the securities which were dematerialized are listed on the Stock Exchanges where the earlier issued securities are listed. . We request you to take this information on record.
07-01-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window

This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insider''s of the company, the trading window for dealing in the Company shares will remain closed from January 1st , 2023 till the end of 48 hours after declaration of audited financial results for the quarter ending on 31st December 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company. The date of Board Meeting for declaration of the financial results of the Company for the quarter ended December 31st 2022 will be intimated in the due course.
31-12-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Appointment Of Karthik Veermani As Additional Director And An Independent Director Subject To Approval Of Shareholders

Pursuant to Regulation 30(2) read with Schedule III Part A Para 7 of SEBI (Listing Obligation and Disclosures Requirements) 2015, The board of Directors by way of circular resolution, subsequent to the recommendation of Nomination and Remuneration committee, have appointed Mr Karthik Veeramani holding (DIN: 07097588) as an Additional Director and an Independent Director with effect from 21.12.2022 subject to approval of shareholders either through Extra-ordinary General Meeting or Postal ballot.
21-12-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith the copy of Newspaper Advertisement published on November 15th and November 16th, 2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on November 14, 2022.
16-11-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Related Party Transaction Under Regulation 23(9)

Related Party Transaction for the half year ended 30th September 2022
14-11-2022
Next Page
Close

Let's Open Free Demat Account